NAU Urology Specialists Offers Patients New Treatment Options Through Clinical Research
Austin, Texas, April 10, 2018 (Business Wire) – Patients of NAU Urology Specialists will now have additional treatment options through the practice’s expansion into clinical research. To help it offer this new service, NAU has partnered with Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients. By offering clinical trials, NAU Urology Specialists can introduce the latest advances in research to its patients in the same location where they currently receive care. As a result, NAU patients now have access to potential new therapies they otherwise would not have. In addition, by conducting clinical research, NAU and its clinical trial participants are playing a role in advancing health care around the world. “Our partnership with Elligo is already providing new options to our patients,” said Sandeep Mistry, M.D., MPH, MBA, of NAU Urology Specialists. “For example, one 84-year-old woman with bladder cancer was ineligible for standard treatment but is now participating in a trial investigating a potential new therapy being developed for patients like her. Elligo’s unique approach of providing clinical trial infrastructure at no cost made offering trials feasible for us. We’re looking forward to being a part of the Elligo network.” “Elligo is delighted to add NAU Urology Specialists to our clinical network,” said John Potthoff, Ph.D., CEO of Elligo Health Research. “NAU will continue to provide the exceptional level of care for which it is known because we offer the personnel, processes, technology and infrastructure to make the clinical research process easier for practices, enabling them to focus on taking care of patients.” About NAU Urology Specialists Dr. Sandeep Mistry founded North Austin Urology in 2007 as a solo practice serving Austin and Greater Williamson County based on a desire to give state-of-the-art urological care and to be accessible and willing to go the extra mile for his patients. Since that time, the practice has grown to represent the best of urologic care. Dr. Stacy Ong joined the practice in 2013 after seven years as a urologist at Brackenridge Hospital and Dr. Christopher Yang joined in 2015 after completion of a fellowship in impotence and genital reconstruction, allowing us to expand to four offices and serve Central Texas. In 2017, the practice name was changed to NAU Urology Specialists. For more information, visit our website at www.northaustinurology.com. CONTACT: Lea Studer SCORR Marketing 308.237.5567 lea@scorrmarketing.com
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
